ZMIZ2 enhances the transcriptional activity of androgen receptor(AR) [46], which is highly expressed in HCC and is associated with increased tumor recurrence and decreased overall survival [47–50]. Here, ZMIZ2 is linked to hepatocellular carcinoma.